99mTc(CO)3(NTA): A 99mTc renal tracer with pharmacokinetic properties comparable to those of 131I-OIH in healthy volunteers

Journal of Nuclear Medicine

Volumn 51, Issue 3, 2010, Pages 391-396

  Taylor, Andrew T ^a   Lipowska, Malgorzata ^a   Marzilli, Luigi G ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

131I ortho iodohippuran ( 131I OIH); 99mTc(CO)3(NTA); 99mTc mercaptoacetyltriglycine ( 99mTc MAG3); 99mTc tricarbonyl; Renal radiopharmaceuticals

Indexed keywords

CARBON MONOXIDE NITRILOTRIACETIC ACID TC 99M; ORTHO IODOHIPPURAN I 131; TRACER; UNCLASSIFIED DRUG; IODOHIPPURIC ACID; RADIOACTIVE IODINE; TECHNETIUM 99M TRICARBONYL NITRILOTRIACETIC ACID; TECHNETIUM COMPLEX;

ADULT; AGED; ARTICLE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG PROTEIN BINDING; DRUG UPTAKE; ERYTHROCYTE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PARAMETER; PRIORITY JOURNAL; BLOOD; CHEMISTRY; CLINICAL TRIAL; COMPARATIVE STUDY; HEALTH; KIDNEY; KIDNEY SCINTISCANNING; METABOLISM; MIDDLE AGED; SCINTISCANNING; TIME; URINE;

ADULT; FEMALE; HEALTH; HUMANS; IODINE RADIOISOTOPES; IODOHIPPURIC ACID; KIDNEY; MALE; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; RADIOACTIVE TRACERS; RADIOISOTOPE RENOGRAPHY; TIME FACTORS; YOUNG ADULT;

EID: 77950191832     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.109.070813     Document Type: Article

References (34)

1. Marcus CS, Kuperus JH. Pediatric renal iodine-123 orthoiodohippurate dosimetry. J Nucl Med. 1985;26:1211-1214.
2. Fritzberg AR, Kasina S, Eshima D, Johnson DL. Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement. J Nucl Med. 1986;27:111-116. (Pubitemid 17023179)
3. Taylor A, Eshima D, Fritzberg AR, Christian PE, Kasina S. Comparison of iodine-131 OIH and technetium-99m MAG3 renal imaging in volunteers. J Nucl Med. 1986;27:795-803. (Pubitemid 17022667)
4. Russell CD, Thorstad B, Yester MV, Stutzman M, Baker T, Dubovsky EV. Comparison of technetium-99m MAG3 with iodine-131 hippuran by a simultaneous dual channel technique. J Nucl Med. 1988;29:1189-1193.
5. 99mTc-MAG3: dynamic studies in patients with renal disease. Eur J Nucl Med. 1988;14:28-31.
6. 99mTc-mercatoacetyltriglycine extraction and clearance as compared with para-aminohippurate. In: O'Reilly PH, Taylor A, Nally JV, eds. Radionuclides in Nephrourology. Blue Bell, PA: Field & Wood Medical Periodicals, Inc.; 1994:21-26.
7. O'Reilly P, Aurell M, Britton K, et al. Consensus on diuresis renography for investigating the dilated upper urinary tract. J Nucl Med. 1996;37:1872-1876. (Pubitemid 26378381)
8. Gordon I, Colarinha P, Fettich J, et al. Guidelines for standard and diuretic renogram in children. Eur J Nucl Med. 2001;28:BP21-BP30.
9. Bubeck B, Brandau W, Weber E, et al. Pharmacokinetics of technetium-99m-MAG3 in humans. J Nucl Med. 1990;31:1285-1293.
10. Sanchez J, Friedman S, Kempf J, Abdel-Dayem H. Gallbladder activity appearing 6 minutes after the intravenous injection of Tc99m MAG3 simulating a picture of obstructive uropathy of the right kidney. Clin Nucl Med. 1993;18:30-34. (Pubitemid 23061745)
11. Rosen JM. Gallbladder uptake simulating hydronephrosis on Tc-99m MAG3 scintigraphy. Clin Nucl Med. 1993;18:713-714.
12. Jafri RA, Britton KE, Nimmon CC, et al. Technetium-99m MAG3: a comparison with iodine-123 and iodine-131 orthoiodohippurate in patients with renal disorders. J Nucl Med. 1988;29:147-158.
13. 99mTc-MAG3 clearance under clinical conditions. Nucl Med Commun. 1997;18:352-357.
14. Piepsz A, Tondeur M, Kinthaert J, et al. Reproducibility of technetium-99m mercaptoacetylglycine clearance. Eur J Nucl Med. 1996;23:195-198.
15. Eshima D, Fritzberg AR, Taylor A. Tc-99m renal tubular function agents: current status. Semin Nucl Med. 1990;20:28-40.
16. Van Nerom CG, Bormans GM, De Roo MJ, Verbruggen AM. First experience in healthy volunteers with technetium-99m L,L-ethylenedicysteine, a new renal imaging agent. Eur J Nucl Med. 1993;20:738-746.
17. Padhy AK, Bormanji J, Nimmon CC, Solanki KK, Chiwatanratan T, Britton KE. Tc-99m diaminocyclohexane (DACH), a cationic renal tubular agent: first results in man. In: O'Reilly PH, Taylor A, Nally JV, eds. Radionuclides in Nephrology. Blue Bell, PA: Field & Wood Medical Periodicals, Inc.; 1994:1-3.
18. Taylor A, Hansen L, Eshima D, et al. Comparison of technetium-99m-LL-EC isomers in rats and humans. J Nucl Med. 1997;38:821-826. (Pubitemid 27204065)
19. 99mTc-EC. J Nucl Med. 2004;45:885-891.
20. 3 O donor. Inorg Chem. 2004; 43:7774-7783.
21. 3(LAN), as a new renal radiopharmaceutical in humans. J Nucl Med. 2006;47:1032-1040.
22. 3 analogues. Nucl Med Biol. 2007;34: 709-716.
23. 131I-OIH. J Nucl Med. 2009;50:454-460.
24. 3] complex. Tetrahedron Lett. 2004;45:2531-2534.
25. 131I-labeled hippuran. Int J Appl Radiat Isot. 1964;15:95.
26. Taylor A, Manatunga A, Morton K, et al. Multicenter trial validation of a camera-based method to measure Tc-99m mercaptoacetyltriglycine, or Tc-99m MAG3, clearance. Radiology. 1997;204:47-54. (Pubitemid 27281708)
27. Sapirstein LA, Vidt DG, Mandel MJ, Hanusek G. Volumes of distribution and clearance of intravenously injected creatinine in the dog. Am J Physiol. 1955; 181:330-336.
28. 99mTc-MAG3 clearance, MAG3 curve parameters, excretory parameters and residual urine volume. AJR. 2006;187:W610-W617.
29. Budny JA, Arnold JD. Nitrilotriacetate (NTA): human metabolism and its importance in the total safety evaluation program. Toxicol Appl Pharmacol. 1973; 25:48-53.
30. Health Canada. Environmental and Workplace Health. Nitrilotriacetic acid (NTA). 1990. Available at: http://www.hc-sc.gc.ca/ewh-semt/pubs/water-eau/ nitrilotriacetic-acid/index-eng.php. Accessed December 15, 2009.
31. World Health Organization. Nitrilotriacetic Acid in Drinking-Water. Guidelines for Drinking-Water Quality. Health Criteria and Other Supporting Information. Vol 2. 2nd ed. Geneva, Switzerland: World Health Organization; 1996.
32. Anderson RL, Bishop WE, Campbell RL. A review of the environmental and mammalian toxicology of nitrilotriacetic acid. Crit Rev Toxicol. 1985;15:1-102. (Pubitemid 15038217)
33. Fritzberg AR, Kuni CC, Klingensmith WC III, Stevens J, Whitney WP. Synthesis and biological evaluation of Tc-99m N,N′-bis-(mercaptoacetyl)-2, 3-diaminopropionate: a potential replacement of I-131 hippuran. J Nucl Med. 1982;23: 592-598.
34. Klingensmith WC III, Fritzberg AR, Spitzer VM, et al. Clinical evaluation of Tc-99m N,N′-bis(mercaptoacetyl)-2,3-diaminopropanoate as a replacement for I-131 hippurate: concise communication. J Nucl Med. 1984;25:42-48.